Disc Medicine (IRON) Tax Provisions (2023 - 2026)
Disc Medicine (IRON) posted quarterly Tax Provisions of $69000.0 for Q2 2026, up 32.69% year-over-year from $52000.0 in Q2 2025, and down 31.0% quarter-over-quarter from $100000.0 in Q1 2026.
Disc Medicine (IRON) Tax Provisions (2023 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Tax Provisions for 4 consecutive years, with $69000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions rose 32.69% year-over-year to $69000.0; the TTM figure through Jun 2026 stood at -$44.5 million (down 10210.23% YoY), while the FY2025 annual figure was -$44.5 million, down 12630.42% from the prior year.
- Tax Provisions slipped to $69000.0 in Q2 2026 per IRON's latest filing, from $100000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $155000.0 in Q4 2024 and bottomed at -$44.8 million in Q4 2025.
- Historically, Tax Provisions has averaged -$3.6 million across 4 years, with a median of $100000.0 in 2023.
- Annual changes were most pronounced in 2024 — Tax Provisions surged 15600.0% — and 2025, when it sank 28974.84%.
- Disc Medicine's Tax Provisions stood at -$1000.0 in 2023, then soared by 15600.0% to $155000.0 in 2024, then tumbled by 28974.84% to -$44.8 million in 2025, then surged by 100.15% to $69000.0 in 2026.
- Business Quant data shows IRON's Tax Provisions at $69000.0 in Q2 2026, $100000.0 in Q1 2026, and -$44.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Disc Medicine | 3.02 Bn | 3.02 Bn | - | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | -44.76 Mn |
| Sep 30, 2025 | 102,000.00 |
| Dec 31, 2024 | 355,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 23,000.00 |